MY SIZE INC (MYSZ)

US62844N4060 - Common Stock

6.51  +2.29 (+54.27%)

After market: 6.2 -0.31 (-4.76%)

Fundamental Rating

2

Taking everything into account, MYSZ scores 2 out of 10 in our fundamental rating. MYSZ was compared to 280 industry peers in the Software industry. Both the profitability and financial health of MYSZ have multiple concerns. While showing a medium growth rate, MYSZ is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MYSZ has reported negative net income.
In the past year MYSZ has reported a negative cash flow from operations.
In the past 5 years MYSZ always reported negative net income.
In the past 5 years MYSZ always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of MYSZ (-65.17%) is worse than 87.81% of its industry peers.
MYSZ has a Return On Equity of -102.80%. This is in the lower half of the industry: MYSZ underperforms 76.70% of its industry peers.
Industry RankSector Rank
ROA -65.17%
ROE -102.8%
ROIC N/A
ROA(3y)-80.05%
ROA(5y)-119.73%
ROE(3y)-138.28%
ROE(5y)-246.89%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MYSZ has a Gross Margin of 43.96%. This is in the lower half of the industry: MYSZ underperforms 73.84% of its industry peers.
MYSZ's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MYSZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.57%
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYSZ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MYSZ has been increased compared to 5 years ago.
Compared to 1 year ago, MYSZ has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -11.02, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.
MYSZ's Altman-Z score of -11.02 is on the low side compared to the rest of the industry. MYSZ is outperformed by 91.76% of its industry peers.
MYSZ has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
MYSZ has a Debt to Equity ratio of 0.07. This is comparable to the rest of the industry: MYSZ outperforms 53.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -11.02
ROIC/WACCN/A
WACC9.06%

2.3 Liquidity

A Current Ratio of 2.49 indicates that MYSZ has no problem at all paying its short term obligations.
The Current ratio of MYSZ (2.49) is better than 69.18% of its industry peers.
A Quick Ratio of 1.56 indicates that MYSZ should not have too much problems paying its short term obligations.
MYSZ has a Quick ratio (1.56) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.56

More info and screens

6

3. Growth

3.1 Past

MYSZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.07%, which is quite impressive.
MYSZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.89%.
MYSZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 266.60% yearly.
EPS 1Y (TTM)78.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.56%
Revenue 1Y (TTM)43.89%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%-14.7%

3.2 Future

Based on estimates for the next years, MYSZ will show a very strong growth in Earnings Per Share. The EPS will grow by 37.25% on average per year.
MYSZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.77% yearly.
EPS Next Y82.6%
EPS Next 2Y37.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.8%
Revenue Next 2Y16.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MYSZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MYSZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

MYSZ's earnings are expected to grow with 37.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYSZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MY SIZE INC

NASDAQ:MYSZ (12/27/2024, 8:00:01 PM)

After market: 6.2 -0.31 (-4.76%)

6.51

+2.29 (+54.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners4.34%
Inst Owner Change70.4%
Ins Owners9.15%
Ins Owner Change0%
Market Cap8.20M
Analysts82.86
Price Target3.06 (-53%)
Short Float %4.19%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.7%
Min EPS beat(2)-61.76%
Max EPS beat(2)48.36%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.42%
Min Revenue beat(2)-9.85%
Max Revenue beat(2)-2.99%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-40%
PT rev (3m)-40%
EPS NQ rev (1m)-3.17%
EPS NQ rev (3m)49.22%
EPS NY rev (1m)13.86%
EPS NY rev (3m)13.86%
Revenue NQ rev (1m)-16.67%
Revenue NQ rev (3m)-16.67%
Revenue NY rev (1m)-6.98%
Revenue NY rev (3m)-6.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF N/A
P/OCF N/A
P/B 1.84
P/tB 2.36
EV/EBITDA N/A
EPS(TTM)-23.68
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-2.96
FCFYN/A
OCF(TTM)-2.95
OCFYN/A
SpS7.64
BVpS3.54
TBVpS2.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.17%
ROE -102.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.96%
FCFM N/A
ROA(3y)-80.05%
ROA(5y)-119.73%
ROE(3y)-138.28%
ROE(5y)-246.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.57%
GM growth 5YN/A
F-Score5
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 1.56
Altman-Z -11.02
F-Score5
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)23.63%
Cap/Depr(5y)90.84%
Cap/Sales(3y)6.09%
Cap/Sales(5y)38.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.56%
EPS Next Y82.6%
EPS Next 2Y37.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.89%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%-14.7%
Revenue Next Year20.8%
Revenue Next 2Y16.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.45%
OCF growth 3YN/A
OCF growth 5YN/A